AR209172A1 - Procedimiento para la fabricacion de 9alfa 11alfa 15-trihidroxi-15-cicloalquil-16,17,18,19,20-pentanor-prostanoico y el ester metilico - Google Patents

Procedimiento para la fabricacion de 9alfa 11alfa 15-trihidroxi-15-cicloalquil-16,17,18,19,20-pentanor-prostanoico y el ester metilico

Info

Publication number
AR209172A1
AR209172A1 AR263588A AR26358876A AR209172A1 AR 209172 A1 AR209172 A1 AR 209172A1 AR 263588 A AR263588 A AR 263588A AR 26358876 A AR26358876 A AR 26358876A AR 209172 A1 AR209172 A1 AR 209172A1
Authority
AR
Argentina
Prior art keywords
trihidroxi
prostanoico
cicloalkil
9alfa
11alfa
Prior art date
Application number
AR263588A
Other languages
English (en)
Spanish (es)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Application granted granted Critical
Publication of AR209172A1 publication Critical patent/AR209172A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AR263588A 1975-06-13 1976-06-10 Procedimiento para la fabricacion de 9alfa 11alfa 15-trihidroxi-15-cicloalquil-16,17,18,19,20-pentanor-prostanoico y el ester metilico AR209172A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25378/75A GB1517562A (en) 1975-06-13 1975-06-13 Prostane derivatives

Publications (1)

Publication Number Publication Date
AR209172A1 true AR209172A1 (es) 1977-03-31

Family

ID=10226704

Family Applications (1)

Application Number Title Priority Date Filing Date
AR263588A AR209172A1 (es) 1975-06-13 1976-06-10 Procedimiento para la fabricacion de 9alfa 11alfa 15-trihidroxi-15-cicloalquil-16,17,18,19,20-pentanor-prostanoico y el ester metilico

Country Status (15)

Country Link
US (1) US4096337A (de)
JP (1) JPS525744A (de)
AR (1) AR209172A1 (de)
AU (1) AU504692B2 (de)
BE (1) BE842892A (de)
CA (1) CA1063603A (de)
DD (1) DD125862A5 (de)
DE (1) DE2626287A1 (de)
DK (1) DK261276A (de)
FR (1) FR2313920A1 (de)
GB (1) GB1517562A (de)
IE (1) IE43831B1 (de)
NL (1) NL7606268A (de)
SE (1) SE7606584L (de)
ZA (1) ZA763139B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243817A (en) * 1977-03-30 1981-01-06 American Cyanamid Company Prostenoic acids and esters
EP0036730B1 (de) * 1980-03-21 1985-01-02 Sumitomo Chemical Company, Limited Bicyclooctan-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen, ihre pharmazeutische Verwendung und Zwischenprodukte
EP1159266B1 (de) * 1999-03-05 2004-11-03 Duke University C-16 ungesätigte fp-selektive prostaglandin analoge
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ

Also Published As

Publication number Publication date
DD125862A5 (de) 1977-05-25
GB1517562A (en) 1978-07-12
DE2626287A1 (de) 1976-12-30
FR2313920B1 (de) 1978-11-17
NL7606268A (nl) 1976-12-15
BE842892A (fr) 1976-12-13
AU504692B2 (en) 1979-10-25
CA1063603A (en) 1979-10-02
JPS525744A (en) 1977-01-17
US4096337A (en) 1978-06-20
SE7606584L (sv) 1976-12-14
IE43831B1 (en) 1981-06-03
AU1446276A (en) 1977-12-08
FR2313920A1 (fr) 1977-01-07
IE43831L (en) 1976-12-13
DK261276A (da) 1976-12-14
ZA763139B (en) 1977-04-27

Similar Documents

Publication Publication Date Title
AR220512A1 (es) Procedimiento para la preparacion de 3-substituido-5-piridinil-2-(1h)-piridinonas
MX3898E (es) Procedimiento mejorado para la preparacion de triesteres de n-fosfonometilglicina
MX4236E (es) Procedimiento para la preparacion de acidos alcanoicos de heteroarilbenzoxepina
MX4067E (es) Procedimiento para la preparacion de esteres de i-tiazolinil o i-tiazinilbencimidazol
MX143488A (es) Procedimiento para la preparacion de resorcinas
AR213736A1 (es) Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
MX4972E (es) Procedimiento mejorado para la preparacion de 7 beta-oxiimmino-acilcefalosporinas
MX4704E (es) Procedimiento mejorado para la preparacion de ester metilico de alfa-l-aspartil-l-fenilalanina
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX4003E (es) Procedimiento mejorado para la fabricacion de bocadillos
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR208001A1 (es) Procedimiento mejorado para la produccion de uroquinasa
AR209835A1 (es) Procedimiento para la preparacion de elastasa pancreatica
AR210888A1 (es) Procedimiento para la preparacion de nuevas benzamidas 2,4-disustituidas,2,5-disustituidas y 2,4,5-trisustituidas
AR209832A1 (es) Nuevos esteres de acidos n-metoxi - benzimidoiltionotiolfosforicos con propiedades insecticidas y acaricidas,composiciones insecticidas y acaricidas a base de los mismos y procedimiento para la produccion de dichos compuestos
MX3798E (es) Procedimiento para preparar esteres 17-ol de 17-alfa-etinil-4-estren-3-onas o 17 beta-acetil-4-pregnen-3-onas
AR209172A1 (es) Procedimiento para la fabricacion de 9alfa 11alfa 15-trihidroxi-15-cicloalquil-16,17,18,19,20-pentanor-prostanoico y el ester metilico
AR224224A1 (es) Procedimiento para obtener desacetil 890 a1 y desacetil 890 a3
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
MX3739E (es) Procedimiento para la preparacion de acilamino-penicilinas-6-substituida
AR227121A1 (es) Procedimiento para la preparacion de un ester alfaciano-3-fenoxibencilcarboxilico